HDAC1 is Involved in Neuroinflammation and Blood-Brain Barrier Damage in Stroke Pathogenesis

References

• Kuriakose D, Xiao Z. Pathophysiology and treatment of stroke: present status and future perspectives. Int J Mol Sci. 2020;21(20):7609. doi:10.3390/ijms21207609
   PubMed Web of Science ®Google Scholar
• Feigin VL, Stark BA, Johnson CO, et al. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol. 2021;20(10):795–820. doi:10.1016/S1474-4422(21)00252-0
   PubMed Web of Science ®Google Scholar
• Donkor ES. Stroke in the 21(st) century: a snapshot of the burden, epidemiology, and quality of life. Stroke Res Treat. 2018;2018:3238165. doi:10.1155/2018/3238165
   PubMed Web of Science ®Google Scholar
• Katan M, Luft A. Global burden of stroke. Semin Neurol. 2018;38(2):208–211. doi:10.1055/s-0038-1649503
   PubMed Web of Science ®Google Scholar
• Profaci CP, Munji RN, Pulido RS, Daneman R. The blood-brain barrier in health and disease: important unanswered questions. J Exp Med. 2020;217(4). doi:10.1084/jem.20190062
   PubMed Web of Science ®Google Scholar
• Daneman R, Prat A. The blood-brain barrier. Cold Spring Harb Perspect Biol. 2015;7(1):a020412. doi:10.1101/cshperspect.a020412
   PubMed Web of Science ®Google Scholar
• Hampl R, Bicikova M, Sosvorova L. Hormones and the blood-brain barrier. Horm Mol Biol Clin Investig. 2015;21(3):159–164. doi:10.1515/hmbci-2014-0042
   PubMedGoogle Scholar
• Kadry H, Noorani B, Cucullo L. A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020;17(1):69. doi:10.1186/s12987-020-00230-3
   PubMed Web of Science ®Google Scholar
• Cabezas R, Avila M, Gonzalez J, et al. Astrocytic modulation of blood brain barrier: perspectives on Parkinson’s disease. Front Cell Neurosci. 2014;8:211. doi:10.3389/fncel.2014.00211
   PubMed Web of Science ®Google Scholar
• Wong AD, Ye M, Levy AF, Rothstein JD, Bergles DE, Searson PC. The blood-brain barrier: an engineering perspective. Front Neuroeng. 2013;6(7). doi:10.3389/fneng.2013.00007
   PubMedGoogle Scholar
• Keaney J, Campbell M. The dynamic blood-brain barrier. FEBS J. 2015;282(21):4067–4079. doi:10.1111/febs.13412
   PubMed Web of Science ®Google Scholar
• Kristian T, Siesjo BK. Calcium in ischemic cell death. Stroke. 1998;29(3):705–718. doi:10.1161/01.str.29.3.705
   PubMed Web of Science ®Google Scholar
• Woodruff TM, Thundyil J, Tang SC, Sobey CG, Taylor SM, Arumugam TV. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener. 2011;6(1):11. doi:10.1186/1750-1326-6-11
   PubMed Web of Science ®Google Scholar
• Macrez R, Ali C, Toutirais O, et al. Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 2011;10(5):471–480. doi:10.1016/S1474-4422(11)70066-7
   PubMed Web of Science ®Google Scholar
• Chen S, Shao L, Ma L. Cerebral edema formation after stroke: emphasis on blood-brain barrier and the lymphatic drainage system of the brain. Front Cell Neurosci. 2021;15:716825. doi:10.3389/fncel.2021.716825
   PubMed Web of Science ®Google Scholar
• Sorby-Adams AJ, Marcoionni AM, Dempsey ER, Woenig JA, Turner RJ. The role of neurogenic inflammation in blood-brain barrier disruption and development of cerebral oedema following acute central nervous system (CNS) injury. Int J Mol Sci. 2017;18(8):1788. doi:10.3390/ijms18081788
   PubMed Web of Science ®Google Scholar
• Wang WY, Tan MS, Yu JT, Tan L. Role of pro-inflammatory cytokines released from microglia in Alzheimer’s disease. Ann Transl Med. 2015;3(10):136. doi:10.3978/j.issn.2305-5839.2015.03.49
   PubMed Web of Science ®Google Scholar
• Hirsch EC, Breidert T, Rousselet E, Hunot S, Hartmann A, Michel PP. The role of glial reaction and inflammation in Parkinson’s disease. Ann N Y Acad Sci. 2003;991:214–228. doi:10.1111/j.1749-6632.2003.tb07478.x
   PubMed Web of Science ®Google Scholar
• Han X, Zhang E, Shi Y, Song B, Du H, Cao Z. Biomaterial-tight junction interaction and potential impacts. J Mater Chem B. 2019;7(41):6310–6320. doi:10.1039/c9tb01081e
   PubMed Web of Science ®Google Scholar
• Kimura-Ohba S, Yang Y. Oxidative DNA damage mediated by intranuclear MMP activity is associated with neuronal apoptosis in ischemic stroke. Oxid Med Cell Longev. 2016;2016:6927328. doi:10.1155/2016/6927328
   PubMed Web of Science ®Google Scholar
• Qiu YM, Zhang CL, Chen AQ, et al. Immune cells in the BBB disruption after acute ischemic stroke: targets for immune therapy? Front Immunol. 2021;12:678744. doi:10.3389/fimmu.2021.678744
   PubMed Web of Science ®Google Scholar
• Yang C, Hawkins KE, Dore S, Candelario-Jalil E. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol Cell Physiol. 2019;316(2):C135–C153. doi:10.1152/ajpcell.00136.2018
   PubMed Web of Science ®Google Scholar
• Peserico A, Simone C. Physical and functional HAT/HDAC interplay regulates protein acetylation balance. J Biomed Biotechnol. 2011;2011:371832. doi:10.1155/2011/371832
   PubMedGoogle Scholar
• Bardai FH, Price V, Zaayman M, Wang L, D’Mello SR. Histone deacetylase-1 (HDAC1) is a molecular switch between neuronal survival and death. J Biol Chem. 2012;287(42):35444–35453. doi:10.1074/jbc.M112.394544
   PubMed Web of Science ®Google Scholar
• Demyanenko SV, Dzreyan VA, Neginskaya MA, Uzdensky AB. Expression of histone deacetylases HDAC1 and HDAC2 and their role in apoptosis in the penumbra induced by photothrombotic stroke. Mol Neurobiol. 2020;57(1):226–238. doi:10.1007/s12035-019-01772-w
   PubMed Web of Science ®Google Scholar
• Kim D, Frank CL, Dobbin MM, et al. Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity. Neuron. 2008;60(5):803–817. doi:10.1016/j.neuron.2008.10.015
   PubMed Web of Science ®Google Scholar
• Kim JY, Shen S, Dietz K, et al. HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage. Nat Neurosci. 2010;13(2):180–189. doi:10.1038/nn.2471
   PubMed Web of Science ®Google Scholar
• Chen JS, Wang HK, Hsu CY, et al. HDAC1 deregulation promotes neuronal loss and deficit of motor function in stroke pathogenesis. Sci Rep. 2021;11(1):16354. doi:10.1038/s41598-021-95837-3
   PubMed Web of Science ®Google Scholar
• Chen JS, Wang HK, Su YT, et al. Restoration of HDAC1 enzymatic activity after stroke protects neurons from ischemia/reperfusion damage and attenuates behavioral deficits in rats. Int J Mol Sci. 2021;22(19). doi:10.3390/ijms221910654
   Web of Science ®Google Scholar
• Horie N, Maag AL, Hamilton SA, Shichinohe H, Bliss TM, Steinberg GK. Mouse model of focal cerebral ischemia using endothelin-1. J Neurosci Methods. 2008;173(2):286–290. doi:10.1016/j.jneumeth.2008.06.013
   PubMed Web of Science ®Google Scholar
• Nakazaki M, Sasaki M, Kataoka-Sasaki Y, et al. Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats. J Neurosurg. 2017;127(4):917–926. doi:10.3171/2016.8.JNS16240
   PubMed Web of Science ®Google Scholar
• Wu CC, Lien CC, Hou WH, Chiang PM, Tsai KJ. Gain of BDNF function in engrafted neural stem cells promotes the therapeutic potential for alzheimer’s disease. Sci Rep. 2016;6:27358. doi:10.1038/srep27358
   PubMed Web of Science ®Google Scholar
• Du L, Wang D, Wei X, et al. MS275 as Class I HDAC inhibitor displayed therapeutic potential on malignant ascites by iTRAQ-based quantitative proteomic analysis. BMC Gastroenterol. 2022;22(1):29. doi:10.1186/s12876-022-02101-7
   PubMed Web of Science ®Google Scholar
• Ihezie SA, Mathew IE, McBride DW, Dienel A, Blackburn SL, Thankamani Pandit PK. Epigenetics in blood-brain barrier disruption. Fluids Barriers CNS. 2021;18(1):17. doi:10.1186/s12987-021-00250-7
   PubMed Web of Science ®Google Scholar
• Wang Z, Leng Y, Tsai LK, Leeds P, Chuang DM. Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J Cereb Blood Flow Metab. 2011;31(1):52–57. doi:10.1038/jcbfm.2010.195
   PubMed Web of Science ®Google Scholar
• Su L, Liang D, Kuang SY, Dong Q, Han X, Wang Z. Neuroprotective mechanism of TMP269, a selective class IIA histone deacetylase inhibitor, after cerebral ischemia/reperfusion injury. Neural Regen Res. 2020;15(2):277–284. doi:10.4103/1673-5374.265562
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hu DN, Zhu Y, et al. Regulation of matrix metalloproteinase-2 secretion from scleral fibroblasts and retinal pigment epithelial cells by miR-29a. Biomed Res Int. 2017;2017:2647879. doi:10.1155/2017/2647879
   PubMed Web of Science ®Google Scholar
• Li H, Sun J, Wang F, et al. Sodium butyrate exerts neuroprotective effects by restoring the blood-brain barrier in traumatic brain injury mice. Brain Res. 2016;1642:70–78. doi:10.1016/j.brainres.2016.03.031
   PubMed Web of Science ®Google Scholar
• Park MJ, Sohrabji F. The histone deacetylase inhibitor, sodium butyrate, exhibits neuroprotective effects for ischemic stroke in middle-aged female rats. J Neuroinflammation. 2016;13(1):300. doi:10.1186/s12974-016-0765-6
   PubMedGoogle Scholar
• Shi W, Wei X, Wang Z, et al. HDAC9 exacerbates endothelial injury in cerebral ischaemia/reperfusion injury. J Cell Mol Med. 2016;20(6):1139–1149. doi:10.1111/jcmm.12803
   PubMed Web of Science ®Google Scholar
• Zhao Q, Yu Z, Zhang F, et al. HDAC3 inhibition prevents oxygen glucose deprivation/reoxygenation-induced transendothelial permeability by elevating PPARgamma activity in vitro. J Neurochem. 2019;149(2):298–310. doi:10.1111/jnc.14619
   PubMed Web of Science ®Google Scholar
• Chen PS, Wang CC, Bortner CD, et al. Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity. Neuroscience. 2007;149(1):203–212. doi:10.1016/j.neuroscience.2007.06.053
   PubMed Web of Science ®Google Scholar
• Kanski R, Sneeboer MA, van Bodegraven EJ, et al. Histone acetylation in astrocytes suppresses GFAP and stimulates a reorganization of the intermediate filament network. J Cell Sci. 2014;127(Pt 20):4368–4380. doi:10.1242/jcs.145912
   PubMed Web of Science ®Google Scholar
• Kannan V, Brouwer N, Hanisch UK, Regen T, Eggen BJ, Boddeke HW. Histone deacetylase inhibitors suppress immune activation in primary mouse microglia. J Neurosci Res. 2013;91(9):1133–1142. doi:10.1002/jnr.23221
   PubMed Web of Science ®Google Scholar
• Shim S, Kim S, Choi DS, Kwon YB, Kwon J. Anti-inflammatory effects of [6]-shogaol: potential roles of HDAC inhibition and HSP70 induction. Food Chem Toxicol. 2011;49(11):2734–2740. doi:10.1016/j.fct.2011.08.012
   PubMed Web of Science ®Google Scholar
• Suh HS, Choi S, Khattar P, Choi N, Lee SC. Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes. J Neuroimmune Pharmacol. 2010;5(4):521–532. doi:10.1007/s11481-010-9192-0
   PubMed Web of Science ®Google Scholar
• Shen Y, Yang R, Zhao J, et al. The histone deacetylase inhibitor belinostat ameliorates experimental autoimmune encephalomyelitis in mice by inhibiting TLR2/MyD88 and HDAC3/ NF-kappaB p65-mediated neuroinflammation. Pharmacol Res. 2022;176:105969. doi:10.1016/j.phrs.2021.105969
   PubMed Web of Science ®Google Scholar
• Gong Y, Liu YC, Ding XL, Fu Y, Cui LJ, Yan YP. Tanshinone IIA ameliorates CNS autoimmunity by promoting the differentiation of regulatory T cells. Neurotherapeutics. 2020;17(2):690–703. doi:10.1007/s13311-019-00789-2
   PubMed Web of Science ®Google Scholar
• Sung MS, Heo H, Eom GH, et al. HDAC2 regulates glial cell activation in ischemic mouse retina. Int J Mol Sci. 2019;20(20):5159. doi:10.3390/ijms20205159
   PubMed Web of Science ®Google Scholar
• Zhao Y, Mu H, Huang Y, et al. Microglia-specific deletion of histone deacetylase 3 promotes inflammation resolution, white matter integrity, and functional recovery in a mouse model of traumatic brain injury. J Neuroinflammation. 2022;19(1):201. doi:10.1186/s12974-022-02563-2
   PubMed Web of Science ®Google Scholar
• Liao Y, Cheng J, Kong X, et al. HDAC3 inhibition ameliorates ischemia/reperfusion-induced brain injury by regulating the microglial cGAS-STING pathway. Theranostics. 2020;10(21):9644–9662. doi:10.7150/thno.47651
   PubMed Web of Science ®Google Scholar
• Sun W, Zhang N, Liu B, et al. HDAC3 Inhibitor RGFP966 ameliorated neuroinflammation in the cuprizone-induced demyelinating mouse model and LPS-Stimulated BV2 cells by downregulating the P2X7R/STAT3/NF-kappaB65/NLRP3 activation. ACS Chem Neurosci. 2022;13:2579–2598. doi:10.1021/acschemneuro.1c00826
   PubMed Web of Science ®Google Scholar
• Bian HT, Xiao L, Liang L, Xie YP, Wang HL, Wang GH. RGFP966 is protective against lipopolysaccharide-induced depressive-like behaviors in mice by inhibiting neuroinflammation and microglial activation. Int Immunopharmacol. 2021;101(Pt B):108259. doi:10.1016/j.intimp.2021.108259
   PubMedGoogle Scholar
• Matheson R, Chida K, Lu H, et al. Neuroprotective effects of selective inhibition of histone deacetylase 3 in experimental stroke. Transl Stroke Res. 2020;11(5):1052–1063. doi:10.1007/s12975-020-00783-3
   PubMed Web of Science ®Google Scholar
• Lin FL, Yen JL, Kuo YC, et al. HADC8 Inhibitor WK2-16 therapeutically targets lipopolysaccharide-induced mouse model of neuroinflammation and microglial activation. Int J Mol Sci. 2019;20(2). doi:10.3390/ijms20020410
   Web of Science ®Google Scholar
• Song Y, Qin L, Yang R, et al. Inhibition of HDAC6 alleviating lipopolysaccharide-induced p38MAPK phosphorylation and neuroinflammation in mice. Pharm Biol. 2019;57(1):263–268. doi:10.1080/13880209.2018.1563620
   PubMed Web of Science ®Google Scholar
• Takata F, Nakagawa S, Matsumoto J, Dohgu S. Blood-brain barrier dysfunction amplifies the development of neuroinflammation: understanding of cellular events in brain microvascular endothelial cells for prevention and treatment of BBB dysfunction. Front Cell Neurosci. 2021;15:661838. doi:10.3389/fncel.2021.661838
   PubMed Web of Science ®Google Scholar
• Huang X, Hussain B, Chang J. Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms. CNS Neurosci Ther. 2021;27(1):36–47. doi:10.1111/cns.13569
   PubMed Web of Science ®Google Scholar
• Varvel NH, Neher JJ, Bosch A, et al. Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus. Proc Natl Acad Sci U S A. 2016;113(38):E5665–74. doi:10.1073/pnas.1604263113
   PubMed Web of Science ®Google Scholar
• Wang J, Zhao H, Fan Z, et al. Long noncoding RNA H19 promotes neuroinflammation in ischemic stroke by driving histone deacetylase 1-dependent M1 microglial polarization. Stroke. 2017;48(8):2211–2221. doi:10.1161/STROKEAHA.117.017387
   PubMed Web of Science ®Google Scholar
• Ji J, Wang J, Yang J, et al. The Intra-nuclear SphK2-S1P axis facilitates M1-to-M2 shift of microglia via suppressing HDAC1-Mediated KLF4 deacetylation. Front Immunol. 2019;10:1241. doi:10.3389/fimmu.2019.01241
   PubMed Web of Science ®Google Scholar
• Durham BS, Grigg R, Wood IC. Inhibition of histone deacetylase 1 or 2 reduces induced cytokine expression in microglia through a protein synthesis independent mechanism. J Neurochem. 2017;143(2):214–224. doi:10.1111/jnc.14144
   PubMed Web of Science ®Google Scholar
• McColl BW, Rothwell NJ, Allan SM. Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J Neurosci. 2007;27(16):4403–4412. doi:10.1523/JNEUROSCI.5376-06.2007
   PubMed Web of Science ®Google Scholar
• Aizawa H, Makita Y, Sumitomo K, et al. Edaravone diminishes free radicals from circulating neutrophils in patients with ischemic brain attack. Intern Med. 2006;45(1):1–4. doi:10.2169/internalmedicine.45.1491
   PubMed Web of Science ®Google Scholar
• Simi A, Tsakiri N, Wang P, Rothwell NJ. Interleukin-1 and inflammatory neurodegeneration. Biochem Soc Trans. 2007;35(Pt 5):1122–1126. doi:10.1042/BST0351122
   PubMedGoogle Scholar
• Pawluk H, Wozniak A, Grzesk G, et al. The role of selected pro-inflammatory cytokines in pathogenesis of ischemic stroke. Clin Interv Aging. 2020;15:469–484. doi:10.2147/CIA.S233909
   PubMed Web of Science ®Google Scholar